BNT162b2 mRNA COVID-19 vaccine-induced antibodies wane over six month period
As vaccination programs around the globe are beginning to slow, the transmission of coronavirus 2019 (COVID-19) has risen again, with
Read more
People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has mutated since its initial emergence in Wuhan, China, in late 2019.
Read more
Could the activation of FcγRIII/CD16 by anti-spike SARS-CoV-2 antibodies independently determine COVID-19 severity?
A team of scientists from Germany recently investigated whether hyperactivation of immune receptors that recognize the Fc part of an
Read more
Study investigates difficulty swallowing in critically ill COVID-19 patients
An analysis was conducted in order to determine the swallowing problems of COVID-19 patients who had tracheostomy or mechanical ventilation.
Read more
Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study
T follicular helper (Tfh) cells are indispensable to the generation of long-lasting immune memory. These are involved in the production
Read more
About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study
It is still unclear how the immune system’s antibodies target and attack certain viruses, particularly the novel severe acute respiratory
Read more